Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
The Methodist Hospital Research Institute
🇺🇸
United States
Country
🇺🇸
United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Temozolomide and Topotecan in Treating Patients With Primary CNS Lymphoma
Not Applicable
Withdrawn
Conditions
Central Nervous System Tumors
Lymphoma
Interventions
Drug: temozolomide
Drug: topotecan hydrochloride
Subscribe
First Posted Date
2005-05-04
Last Posted Date
2017-09-19
Lead Sponsor
The Methodist Hospital Research Institute
Registration Number
NCT00109798
Subscribe
Prev
1
9
10
11
12
13
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy